Genetic polymorphisms of cytochrome P4502B6 gene in Han Chinese

被引:40
|
作者
Guan, Su
Huang, Min
Chan, Eli
Chen, Xiao
Duan, Wei
Zhou, Shu-Feng
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510080, Peoples R China
[2] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou 510080, Peoples R China
[4] Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 117548, Singapore
基金
中国国家自然科学基金;
关键词
CYP2B6; Chinese; single nucleotide polymorphism; ethnicity;
D O I
10.1016/j.ejps.2006.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (CYP2B6) is an important enzyme that metabolizes more than eight compounds and about 3.0% of therapeutic drugs. The genetic polymorphisms of CYP2B6 have earlier been studied in Caucasian, Japanese and Korean, but the data are lacking for Han Chinese. The aim of this study was to investigate the frequencies of allelic variants of CYP2B6 in healthy Han Chinese and compare with those in other ethnic groups reported in the literature. Polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method was used to test the five common non-synonymous single nucleotide polymorphisms (SNPs) of CYP2B6 gene, namely, 64C > T, 516G > T, 777C > A, 785A > G and 1459C > T in unrelated healthy Han Chinese (n = 193). The study demonstrated that the frequencies of 64C > T, 516G > T, 777C > A, 785A > G and 1459C > T SNPs in Han Chinese were 0.03, 0.21, 0, 0.28 and 0.003, respectively. The frequencies of all five SNPs tested in female were higher than those in male, but the statistical difference was insignificant (P > 0.05). Compared to the data reported in the literature, the frequencies of common CYP2B6 allelic variants in Chinese are similar to those of other Asian populations including Japanese and Korean, but markedly different from those in Caucasians. These results indicate the presence of marked ethnic difference in CYP2B6 SNP frequencies between Chinese and Caucasian. Further studies are required to explore the impact of these SNPs of CYP2B6 gene on the clinical response (efficacy and toxicity) to drugs that are substrates for CYP2B6 in patients. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [1] Aberrant splicing of the cytochrome P4502B6 gene
    Alrohaimi, AA
    Hesse, LM
    Hao, Q
    Foy, MT
    Krishnaswamy, S
    Court, MH
    DRUG METABOLISM REVIEWS, 2003, 35 : 64 - 64
  • [2] Role of Cytochrome P4502B6 Polymorphisms in Ketamine Metabolism and Clearance
    Rao, Lesley K.
    Flaker, Alicia M.
    Friedel, Christina C.
    Kharasch, Evan D.
    ANESTHESIOLOGY, 2016, 125 (06) : 1103 - 1112
  • [3] Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P4502B6 of potential clinical relevance
    Rohrbacher, Maren
    Kirchhof, Anja
    Geisslinger, Gerd
    Loetsch, Joern
    PHARMACOGENOMICS, 2006, 7 (07) : 995 - 1002
  • [4] Genetic polymorphism of cytochrome P4502B6 in a Korean population.
    Lee, S
    Kim, S
    Jeong, H
    Shon, J
    Yoon, Y
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P68 - P68
  • [5] Cloning of the human cytochrome P4502B6 gene in Escherichia coli cells
    Kolomeichuk, SN
    Pokrovskaya, MV
    Borisova, AA
    Jgoun, AA
    Solodar, LI
    Sokolov, NN
    Shvets, VI
    Gervaziev, YV
    Eldarov, MA
    Archakov, AI
    VOPROSY MEDITSINSKOI KHIMII, 2001, 47 (06): : 609 - 619
  • [6] Intra- and inter-ethnic differences in the allele frequencies of cytochrome P4502B6 gene in Chinese
    Guan, Su
    Huang, Min
    Li, Xin
    Chen, Xiao
    Chan, Eli
    Zhou, Shu-Feng
    PHARMACEUTICAL RESEARCH, 2006, 23 (09) : 1983 - 1990
  • [7] Functional characterization of cytochrome P4502B6 allelic variants
    Jinno, H
    Tanaka-Kagawa, T
    Ohno, A
    Makino, Y
    Matsushima, E
    Hanioka, N
    Ando, M
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (04) : 398 - 403
  • [8] Role of Cytochrome P4502B6 in Methadone Metabolism and Clearance
    Kharasch, Evan D.
    Stubbert, Kristi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (03): : 305 - 313
  • [9] Evaluation of 227 drugs for in vitro inhibition of cytochrome P4502B6
    Walsky, Robert L.
    Astuccio, Angela V.
    Obach, R. Scott
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12): : 1426 - 1438
  • [10] The importance of cytochrome P4502B6 in the human metabolism of environmental chemicals
    Hodgson, Ernest
    Rose, Randy L.
    PHARMACOLOGY & THERAPEUTICS, 2007, 113 (02) : 420 - 428